MiMedx Group, Inc (MDXG) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and thank you for standing by. Welcome to today's MyMedx Investor Conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Matt Notarianni, Head of Investor Relations for MyMedx. Thank you. You may begin. Thank you, Operator, and good afternoon, everyone. We are excited to welcome you to today's conference call, where we will discuss our recently announced plans to acquire Scenara MedTech, as well as MyMedx's second quarter 2026 operating and financial results. With me on today's call are Chief Executive Officer Joe Capper and Chief Financial Officer Doug Rice. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the investor relations website at mymedx.com. Joe will kick us off with some opening remarks about the scenario transaction before we continue with the summary of our second quarter 2026 operating and financial results highlights. And Doug will provide a detailed review of our results for the quarter. Then we will conclude with some additional updates before we open the line for your questions. Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, operating results and cash balance growth, future margins and expenses, our product portfolios, expected market sizes for our products, and expectations regarding the scenario acquisition, including expected benefits and financial performance of the combined company. These expectations are subject to risks and uncertainties, and actual result...